Larry Wayne Kraiss
Physician in Salt Lake City, UT
License number
Utah 294502-1205
Issued Date
Aug 3, 1995
Expiration Date
Jan 31, 2018
Category
Physician
Type
Physician & Surgeon
Address
Address
Salt Lake City, UT
Personal information
See more information about Larry Wayne Kraiss at radaris.comName
Address
Phone
711 16Th Ave, Salt Lake Cty, UT 84103
S Salt Lake, UT
711 16Th Ave, Salt Lake City, UT 84103
711 16Th Ave, Salt Lake Cty, UT 84103
Professional information
Professor At University Of Utah
Position:
Professor at University of Utah
Location:
Greater Salt Lake City Area
Industry:
Medical Practice
Work:
University of Utah
-
Professor
Larry Kraiss, Salt Lake City UT
Work:
Uumc Vascular Sugery Dept
50 N Medical Dr, Salt Lake City, UT 84132 Va Salt Lake City Health Care System
500 Foothill Dr, Salt Lake City, UT 84148
50 N Medical Dr, Salt Lake City, UT 84132 Va Salt Lake City Health Care System
500 Foothill Dr, Salt Lake City, UT 84148
Larry W Kraiss, Salt Lake City UT
Specialties:
Vascular Surgeon
Address:
50 N Medical Dr, Salt Lake City, UT 84132
30 N 1900 E, Salt Lake City, UT 84132
30 N 1900 E, Salt Lake City, UT 84132
Education:
Baylor University, College of Medicine - Doctor of Medicine
Board certifications:
American Board of Surgery Certification in Surgery, American Board of Surgery Certification in Vascular Surgery (Surgery)
Terminally-Differentiated Anucleate Platelet Progeny Generation
US Patent:
2011029, Dec 1, 2011
Filed:
Oct 7, 2009
Appl. No.:
13/122886
Inventors:
Hansjorg Schwertz - Salt Lake City UT, US
Robert C. Blaylock - Salt Lake City UT, US
Larry W. Kraiss - Salt Lake City UT, US
Guy A. Zimmerman - Salt Lake City UT, US
Andrew S. Weyrich - Salt Lake City UT, US
Robert C. Blaylock - Salt Lake City UT, US
Larry W. Kraiss - Salt Lake City UT, US
Guy A. Zimmerman - Salt Lake City UT, US
Andrew S. Weyrich - Salt Lake City UT, US
International Classification:
A61K 38/02, A61K 31/7072, A61K 31/551, A61K 31/496, A61K 31/536, A61P 7/00, A61K 31/203, A61K 31/708, A61K 31/7068, A61K 31/513, A61K 31/52, C12N 5/078, A61K 31/505
US Classification:
514 135, 435325, 435391, 514 50, 514220, 51425309, 5142305, 514272, 514559, 514 45, 514 49, 514274, 5142634
Abstract:
Platelets are induced to proliferate, form extensions and produce daughter cells by various methods, including culturing platelets under thrombocytopenic conditions. Expansion of platelet cell numbers increases the storage life of platelets. Modulation of RT activity can be used to produce new daughter platelets. Therefore, the invention provides a new therapeutic use for RT inhibitors that can now be used for treatment of thrombocytopenia and related disorders. Likewise, application of soluble protein factor that may be secreted and/or released by platelets cultured under thrombocytopenic conditions may also be used as a therapeutic agent to increase platelet numbers.